Among the 51 tumors, there was one tumor with EGFR mutations in both the LAMP and the NGS assays, another one with EGFR wild type in the LAMP assay but EGFR mutations in the NGS assay, and the others with EGFR wild type in both assays. Here, EGFR is linked to neoplasm.